Purchase Order 75N95023P00520

Award Date 8/8/23
Potential Completion Date 8/7/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Transnetyx, Inc., a for-profit organization, is for the provision of automated genotyping services to support biomedical research across various federal agencies. The $24,000 firm fixed-price purchase order is being issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx has extensive experience supporting research initiatives at the National Institutes of Health (NIH), including the...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $156,200 firm fixed price purchase order to Biocytogen Boston Corp. to provide services for the transgenic development of HIV-related rats. Per the original solicitation, the contractor will design plasmid and targeting vector construction, complete microinjections and screening in multiple rat lines, and conduct breeding and genotyping to deliver the developed rat lines within...
This firm-fixed-price purchase order, valued at $24,487.45, was awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services to support biomedical research. The contract, which has no set-aside designation, is for genotyping testing services to support NIDA's research initiatives. Transnetyx has held numerous federal contracts to provide genomic...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization that provides automated genotyping services. The $18,000.00 contract is for genotyping services to support biomedical research efforts across various federal agencies. Transnetyx has extensive experience supporting NIH institutes, including NIDA, the National Institute of Neurological...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Transnetyx, Inc. for standing order receptor genetic knockout mice genotyping services. The contract has a potential value of $12,257.25 and a completion date of March 13, 2025. Transnetyx, Inc. is a for-profit organization that provides DNA extraction, gene analysis, bioinformatics, and genotyping...
This federal contract award to Transnetyx, Inc. is for PCR for genotyping services, with a ceiling value of $14,000 and a completion date of February 7, 2025. The contract is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx, Inc., a for-profit organization specializing in automated genotyping, DNA extraction, and bioinformatics services, has extensive experience supporting...
This is a $24,990.75 firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization. The contract is for "AUTOMATED GENOTYPING" services, which includes DNA extraction, multi-gene analysis, and bioinformatics support for biomedical research, particularly involving transgenic rats and mice. Transnetyx is an established provider of genetic testing...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in advanced genetic testing and analysis services. The contract, valued at $19,991.60, is for genotyping services and does not have a set-aside designation, indicating it was awarded through open competition. Transnetyx has established...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Transnetyx, Inc. for animal genotyping services. The contract has an estimated value of $450,000.00 and a period of performance from February to June 2021. Transnetyx, a for-profit organization, will provide DNA extraction, multi-gene analysis, bioinformatics, and genotyping services to support...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Transnetyx, Inc. The contract, valued at $24,999.00, is for automated genotyping services to support research examining the behavior and cellular mechanisms of learning in addiction. Transnetyx, a for-profit organization, provides a range of genomic services to federal agencies, including DNA extraction, gene analysis, and...

This purchase order contract was awarded by the National Institutes of Health's National Institute on Drug Abuse to Transnetyx, Inc., doing business as Harmonyx Diagnostics, for genotyping services for transgenic rats and mice in support of an HIV project. The solicitation sought proposals to provide such services for a one-year base period of performance from August 8, 2023 through August 7, 2024 at a value of $30,000. The contractor will genotype research subjects, provide additional services as needed up to available funds, and ensure timely support and delivery. No subcontractors or set aside designations were identified. The services will aid research efforts at the National Institutes of Health related to HIV/AIDS, a major focus area of the National Institute on Drug Abuse.

Generated 12/24/23, 4:06 AM